.-Previous studies from our laboratory and those of others have shown thyroxine to be a stimulator of coronary microvascular growth. The present study tested the hypothesis that 3,5-diiodothyropropionic acid (DITPA), a thyroid hormone analog with inotropic but not chronotopic characteristics, is angiogenic in the nonischemic heart. Daily injections (3.75 mg/kg sc) of DITPA to Sprague-Dawley rats affected protein increases in vascular endothelial growth factor (VEGF)164, VEGF188, basic fibroblast growth factor (bFGF) (FGF-2), angiopoietin-1, and Tie-2 during the first few days of treatment. After 3 wk of treatment, arteriolar length density and the relative number of terminal arterioles (Ͻ10 m diameter) increased in the left ventricle as determined by image analysis of perfuse-fixed hearts. These findings occurred in hearts that did not undergo changes in mass nor in increases in capillary length density. We conclude that DITPA, which is known to improve ventricular function after infarction, is angiogenic in normal nonischemic hearts. growth factors; angiogenesis; 3,5-diiodothyroproprionic acid; basic fibroblast growth factor; vascular endothelial growth factor CORONARY ANGIOGENESIS during prenatal and postnatal growth is a well-established phenomenon. However, in the nonischemic adult heart, angiogenesis may or may not occur when the heart enlarges. Although some significant vascular growth may occur in certain animal models of hypertension (reviewed in Ref. 28), in patients with long-term left ventricular (LV) hypertrophy due to aortic stenosis, coronary reserve is usually markedly depressed even in the absence of coronary artery disease (5). In contrast, when hypertrophy occurs in response to volume overload, capillary and arteriolar growth are usually proportional to the magnitude of hypertrophy, and maximal coronary perfusion is maintained (2, 28). These findings support the concept that the stimulus evoking the hypertrophy is a determinant of angiogenesis. Perhaps the best example supporting this concept is thyroid hormone-induced hypertrophy, which is associated with a rapid and marked capillary growth (1,3,7,14,(24)(25)(26)30). Moreover, we have documented a normal maximal myocardial perfusion in rat hearts in which hypertrophy was induced with thyroxine, a finding that indicates compensatory growth of resistance vessels as well (25).In a previous study, we showed that 3,5-diiodothyropropionic acid (DITPA), a thyroxine analog, stimulates modest, early growth of the capillary bed in the myocardium surviving infarction (29). This agent has been shown to attenuate symptoms of heart failure after myocardial infarction through its positive inotropic effects (13,15,21). The favorable changes with DITPA treatment of rats or rabbits following coronary artery ligation and infarction include increased maximal positive and negative pressure development over time (dP/dt), increased basal time constant of isovolumic relaxation, and increased circumferential shortening and restoration of repolarizing transient outward...